1. Home
  2. STCN vs MIST Comparison

STCN vs MIST Comparison

Compare STCN & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STCN
  • MIST
  • Stock Information
  • Founded
  • STCN 1986
  • MIST 2003
  • Country
  • STCN United States
  • MIST Canada
  • Employees
  • STCN N/A
  • MIST N/A
  • Industry
  • STCN Advertising
  • MIST Biotechnology: Pharmaceutical Preparations
  • Sector
  • STCN Consumer Discretionary
  • MIST Health Care
  • Exchange
  • STCN Nasdaq
  • MIST Nasdaq
  • Market Cap
  • STCN 63.4M
  • MIST 81.5M
  • IPO Year
  • STCN 1994
  • MIST N/A
  • Fundamental
  • Price
  • STCN $10.40
  • MIST $1.43
  • Analyst Decision
  • STCN
  • MIST Strong Buy
  • Analyst Count
  • STCN 0
  • MIST 3
  • Target Price
  • STCN N/A
  • MIST $13.00
  • AVG Volume (30 Days)
  • STCN 11.9K
  • MIST 177.8K
  • Earning Date
  • STCN 12-12-2024
  • MIST 11-11-2024
  • Dividend Yield
  • STCN N/A
  • MIST N/A
  • EPS Growth
  • STCN 203.29
  • MIST N/A
  • EPS
  • STCN 3.17
  • MIST N/A
  • Revenue
  • STCN $169,044,000.00
  • MIST N/A
  • Revenue This Year
  • STCN N/A
  • MIST N/A
  • Revenue Next Year
  • STCN N/A
  • MIST N/A
  • P/E Ratio
  • STCN $3.19
  • MIST N/A
  • Revenue Growth
  • STCN N/A
  • MIST N/A
  • 52 Week Low
  • STCN $7.36
  • MIST $1.12
  • 52 Week High
  • STCN $13.00
  • MIST $3.52
  • Technical
  • Relative Strength Index (RSI)
  • STCN 57.19
  • MIST 42.50
  • Support Level
  • STCN $9.90
  • MIST $1.41
  • Resistance Level
  • STCN $10.29
  • MIST $1.53
  • Average True Range (ATR)
  • STCN 0.39
  • MIST 0.07
  • MACD
  • STCN 0.11
  • MIST -0.01
  • Stochastic Oscillator
  • STCN 100.00
  • MIST 26.96

About STCN Steel Connect Inc.

Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: